{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T14:13:10Z","timestamp":1773238390827,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,9,26]],"date-time":"2008-09-26T00:00:00Z","timestamp":1222387200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s10549-008-0194-z","type":"journal-article","created":{"date-parts":[[2008,9,25]],"date-time":"2008-09-25T17:02:45Z","timestamp":1222362165000},"page":"577-586","source":"Crossref","is-referenced-by-count":43,"title":["BRCA1\/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy"],"prefix":"10.1007","volume":"116","author":[{"given":"Laura","family":"Ottini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piera","family":"Rizzolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines","family":"Zanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Falchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Masala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ketty","family":"Ceccarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vania","family":"Vezzosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Gulino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simonetta","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Sera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Palli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,9,26]]},"reference":[{"key":"194_CR1","unstructured":"NCI, SEER (Surveillance Epidemiology and End Results) database 2007"},{"key":"194_CR2","doi-asserted-by":"crossref","unstructured":"Speirs V, Shaaban AM (2008) The rising incidence of male breast cancer. Breast Cancer Res Treat (Epub ahead of print)","DOI":"10.1007\/s10549-008-0053-y"},{"key":"194_CR3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(06)68226-3","volume":"367","author":"IS Fentiman","year":"2006","unstructured":"Fentiman IS, Fourquet A, Hortobagyi GN (2006) Male breast cancer. Lancet 367:595\u2013604. doi: 10.1016\/S0140-6736(06)68226-3","journal-title":"Lancet"},{"key":"194_CR4","unstructured":"Zanetti R, Gaf\u00e0 L, Pannelli F, Conti E, Rosso S (eds) (2001) Il cancro in Italia 3. I dati dei Registri Tumori. Volume terzo: 1993\u20131998. Il Pensiero Scientifico Editore, Roma"},{"key":"194_CR5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10549-006-9356-z","volume":"103","author":"A Agrawal","year":"2007","unstructured":"Agrawal A, Ayantunde AA, Rampaul R, Robertson JF (2007) Male breast cancer: a review of clinical management. Breast Cancer Res Treat 103:11\u201321. doi: 10.1007\/s10549-006-9356-z","journal-title":"Breast Cancer Res Treat"},{"key":"194_CR6","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1634\/theoncologist.10-7-471","volume":"10","author":"SH Giordano","year":"2005","unstructured":"Giordano SH (2005) A review of the diagnosis and management of male breast cancer. Oncologist 10:471\u2013479. doi: 10.1634\/theoncologist.10-7-471","journal-title":"Oncologist"},{"issue":"Suppl 6","key":"194_CR7","doi-asserted-by":"crossref","first-page":"vi93","DOI":"10.1093\/annonc\/mdm234","volume":"18","author":"R Ferla","year":"2007","unstructured":"Ferla R, Calo V, Cascio S (2007) Founder mutations in BRCA1 and BRCA2 genes. Ann Oncol 18(Suppl 6):vi93\u2013vi98. doi: 10.1093\/annonc\/mdm234","journal-title":"Ann Oncol"},{"key":"194_CR8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/humu.1167","volume":"18","author":"F Baudi","year":"2001","unstructured":"Baudi F, Quaresima B, Grandinetti C, Cuda G, Faniello C, Tassone P et al (2001) Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast\/ovarian cancer. Hum Mutat 18:163\u2013164. doi: 10.1002\/humu.1167","journal-title":"Hum Mutat"},{"key":"194_CR9","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1054\/bjoc.1999.0963","volume":"82","author":"M Pisano","year":"2000","unstructured":"Pisano M, Cossu A, Persico I, Palmieri G, Angius A, Casu G et al (2000) Identification of a founder BRCA2 mutation in Sardinia. Br J Cancer 82:553\u2013559. doi: 10.1054\/bjoc.1999.0963","journal-title":"Br J Cancer"},{"key":"194_CR10","doi-asserted-by":"crossref","unstructured":"Russo A, Calo V, Bruno L, Schiro V, Agnese V, Cascio S et al (2008) Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation? Breast Cancer Res Treat (Epub ahead of print)","DOI":"10.1007\/s10549-008-9906-7"},{"key":"194_CR11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1200\/JCO.2007.13.2118","volume":"26","author":"S Malacrida","year":"2008","unstructured":"Malacrida S, Agata S, Callegaro M, Casella C, Barana D, Scaini MC et al (2008) BRCA1 p.Val1688del is a deleterious mutation that recurs in breast and ovarian cancer families from Northeast Italy. J Clin Oncol 26:26\u201331. doi: 10.1200\/JCO.2007.13.2118","journal-title":"J Clin Oncol"},{"key":"194_CR12","doi-asserted-by":"crossref","first-page":"8143","DOI":"10.1158\/0008-5472.CAN-04-2467","volume":"64","author":"I Tournier","year":"2004","unstructured":"Tournier I, Paillerets BB, Sobol H, Stoppa-Lyonnet D, Lidereau R, Barrois M et al (2004) Significant contribution of germline BRCA2 rearrangements in male breast cancer families. Cancer Res 64:8143\u20138147. doi: 10.1158\/0008-5472.CAN-04-2467","journal-title":"Cancer Res"},{"key":"194_CR13","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1136\/jmg.2004.027961","volume":"42","author":"AM Woodward","year":"2005","unstructured":"Woodward AM, Davis TA, Silva AG, Kirk JA, Leary JA (2005) kConFab investigators. Large genomic rearrangements of both BRCA2 and BRCA1 are a feature of the inherited breast\/ovarian cancer phenotype in selected families. J Med Genet 42:e31. doi: 10.1136\/jmg.2004.027961","journal-title":"J Med Genet"},{"key":"194_CR14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10549-006-9376-8","volume":"103","author":"S Gutierrez-Enriquez","year":"2006","unstructured":"Gutierrez-Enriquez S, de La Hoya M, Martinez-Bouzas C, De Abajo AS, Cajal TR, Llort G et al (2006) Screening for large rearrangements of the BRCA2 gene in Spanish families with breast\/ovarian cancer. Breast Cancer Res Treat 103:103\u2013107. doi: 10.1007\/s10549-006-9376-8","journal-title":"Breast Cancer Res Treat"},{"key":"194_CR15","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1200\/JCO.2006.06.9443","volume":"25","author":"PM Machado","year":"2007","unstructured":"Machado PM, Brandao RD, Cavaco BM, Eugenio J, Bento S, Nave M et al (2007) Screening for a BRCA2 rearrangement in high-risk breast\/ovarian cancer families: evidence for a founder effect and analysis of the associated phenotypes. J Clin Oncol 25:2027\u20132034. doi: 10.1200\/JCO.2006.06.9443","journal-title":"J Clin Oncol"},{"key":"194_CR16","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jama.295.12.1379","volume":"295","author":"T Walsh","year":"2006","unstructured":"Walsh T, Casadei S, Coats KH, Swisher E, Stray SM, Higgins J et al (2006) Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA 295:1379\u20131388. doi: 10.1001\/jama.295.12.1379","journal-title":"JAMA"},{"key":"194_CR17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10549-007-9689-2","volume":"110","author":"M Falchetti","year":"2008","unstructured":"Falchetti M, Lupi R, Rizzolo P, Ceccarelli K, Zanna I, Cal\u00f2 V et al (2008) BRCA1\/2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases. Breast Cancer Res Treat 110:161\u2013167. doi: 10.1007\/s10549-007-9689-2","journal-title":"Breast Cancer Res Treat"},{"key":"194_CR18","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/cncr.22589","volume":"109","author":"ZA Nahleh","year":"2007","unstructured":"Nahleh ZA, Srikantiah R, Safa M, Jazieh AR, Muhleman A, Komrokji R (2007) Male breast cancer in the veterans affairs population: a comparative analysis. Cancer 109:1471\u20131477. doi: 10.1002\/cncr.22589","journal-title":"Cancer"},{"key":"194_CR19","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.1038\/sj.onc.1209875","volume":"25","author":"E Honrado","year":"2006","unstructured":"Honrado E, Osorio A, Palacios J, Benitez J (2006) Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations. Oncogene 25:5837\u20135845. doi: 10.1038\/sj.onc.1209875","journal-title":"Oncogene"},{"key":"194_CR20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/01.pas.0000213351.49767.0f","volume":"31","author":"AL Bane","year":"2007","unstructured":"Bane AL, Beck JC, Bleiweiss I, Buys SS, Catalano E, Daly MB et al (2007) BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays. Am J Surg Pathol 31:121\u2013128. doi: 10.1097\/01.pas.0000213351.49767.0f","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"194_CR21","first-page":"4452","volume":"9","author":"E Kwiatkowska","year":"2003","unstructured":"Kwiatkowska E, Teresiak M, Filas V, Karczewska A, Breborowicz D, Mackiewicz A (2003) BRCA2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patients. Clin Cancer Res 9(12):4452\u20134459","journal-title":"Clin Cancer Res"},{"key":"194_CR22","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00428-006-0305-3","volume":"449","author":"AM Burga","year":"2006","unstructured":"Burga AM, Fadare O, Lininger RA, Tavassoli FA (2006) Invasive carcinomas of the male breast: a morphologic study of the distribution of histologic subtypes and metastatic patterns in 778 cases. Virchows Arch 449:507\u2013512. doi: 10.1007\/s00428-006-0305-3","journal-title":"Virchows Arch"},{"key":"194_CR23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10689-007-9153-9","volume":"7","author":"DG Evans","year":"2008","unstructured":"Evans DG, Bulman M, Young K, Howard E, Bayliss S, Wallace A et al (2008) BRCA1\/2 mutation analysis in male breast cancer families from North West England. Fam Cancer 7:113\u2013117. doi: 10.1007\/s10689-007-9153-9","journal-title":"Fam Cancer"},{"key":"194_CR24","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1593\/neo.04193","volume":"6","author":"K Syrj\u00e4koski","year":"2004","unstructured":"Syrj\u00e4koski K, Kuukasj\u00e4rvi T, Waltering K, Haraldsson K, Auvinen A, Borg A et al (2004) BRCA2 mutations in 154 finnish male breast cancer patients. Neoplasia 6:541\u2013545. doi: 10.1593\/neo.04193","journal-title":"Neoplasia"},{"key":"194_CR25","first-page":"342","volume":"63","author":"L Ottini","year":"2003","unstructured":"Ottini L, Masala G, D\u2019Amico C, Mancini B, Saieva C, Aceto G et al (2003) BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy. Cancer Res 63:342\u2013347","journal-title":"Cancer Res"},{"key":"194_CR26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/301670","volume":"62","author":"G Parmigiani","year":"1998","unstructured":"Parmigiani G, Berry DA, Aguilar O (1998) Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 62:145\u2013158. doi: 10.1086\/301670","journal-title":"Am J Hum Genet"},{"key":"194_CR27","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/jcp.20535","volume":"206","author":"S Bianchi","year":"2006","unstructured":"Bianchi S, Palli D, Falchetti M, Saieva C, Masala G, Mancini B et al (2006) ErbB-receptors expression and survival in breast carcinoma: a 15-year follow-up study. J Cell Physiol 206:702\u2013708. doi: 10.1002\/jcp.20535","journal-title":"J Cell Physiol"},{"key":"194_CR28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10549-006-9448-9","volume":"105","author":"K Dakin Hach\u00e9","year":"2007","unstructured":"Dakin Hach\u00e9 K, Gray S, Barnes PJ, Dewar R, Younis T, Rayson D (2007) Clinical and pathological correlations in male breast cancer: intratumoral aromatase expression via tissue microarray. Breast Cancer Res Treat 105:169\u2013175. doi: 10.1007\/s10549-006-9448-9","journal-title":"Breast Cancer Res Treat"},{"key":"194_CR29","doi-asserted-by":"crossref","first-page":"R2","DOI":"10.1186\/bcr419","volume":"4","author":"VM Basham","year":"2002","unstructured":"Basham VM, Lipscombe JM, Ward JM, Gayther SA, Ponder BA, Easton DF et al (2002) BRCA1 and BRCA2 mutations in a population-based study of male breast cancer. Breast Cancer Res 4:R2. doi: 10.1186\/bcr419","journal-title":"Breast Cancer Res"},{"key":"194_CR30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejmg.2007.11.001","volume":"51","author":"G Chodick","year":"2008","unstructured":"Chodick G, Struewing JP, Ron E, Rutter JL, Iscovich J (2008) Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer: evidence from 261 cases in Israel, 1976\u20131999. Eur J Med Genet 51:141\u2013147. doi: 10.1016\/j.ejmg.2007.11.001","journal-title":"Eur J Med Genet"},{"key":"194_CR31","doi-asserted-by":"crossref","unstructured":"Papi L, Putignano AL, Congregati C, Zanna I, Sera F, Morrone D et al (2008) Founder mutations account for the majority of BRCA1-attributable hereditary breast\/ovarian cancer cases in a population from Tuscany, Central Italy. Breast Cancer Res Treat (in press). doi: 10.1007\/s10549-008-0190-3","DOI":"10.1007\/s10549-008-0190-3"},{"key":"194_CR32","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1200\/JCO.2007.11.4330","volume":"25","author":"C Capalbo","year":"2007","unstructured":"Capalbo C, Buffone A, Vestri A, Ricevuto E, Rinaldi C, Zani M et al (2007) Does the search for large genomic rearrangements impact BRCAPRO carrier prediction? J Clin Oncol 25:2632\u20132634. doi: 10.1200\/JCO.2007.11.4330","journal-title":"J Clin Oncol"},{"key":"194_CR33","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1471-2407-6-156","volume":"6","author":"G Miolo","year":"2006","unstructured":"Miolo G, Puppa LD, Santarosa M, De Giacomi C, Veronesi A, Bidoli E et al (2006) Phenotypic features and genetic characterization of male breast cancer families: identification of two recurrent BRCA2 mutations in North-east of Italy. BMC Cancer 6:156. doi: 10.1186\/1471-2407-6-156","journal-title":"BMC Cancer"},{"key":"194_CR34","first-page":"481","volume":"145","author":"A Pich","year":"1994","unstructured":"Pich A, Chiusa L, Margarina E (1994) Proliferative activity is a significant prognostic factor in male breast carcinoma. Am J Pathol 145:481\u2013489","journal-title":"Am J Pathol"},{"key":"194_CR35","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0960-0760(98)00124-1","volume":"67","author":"MM Mu\u00f1oz de Toro","year":"1998","unstructured":"Mu\u00f1oz de Toro MM, Maffini MV, Kass L, Luque EH (1998) Proliferative activity and steroid hormone receptor status in male breast carcinoma. J Steroid Biochem Mol Biol 67:333\u2013339. doi: 10.1016\/S0960-0760(98)00124-1","journal-title":"J Steroid Biochem Mol Biol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-008-0194-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-008-0194-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-008-0194-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T13:46:35Z","timestamp":1588945595000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-008-0194-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,26]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["194"],"URL":"https:\/\/doi.org\/10.1007\/s10549-008-0194-z","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,26]]}}}